TBPH icon

Theravance Biopharma

132 hedge funds and large institutions have $399M invested in Theravance Biopharma in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
+11
Holders Change %
+9.09%
% of All Funds
1.92%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
25
Increased
43
Reduced
46
Closed
13
Calls
$118K
Puts
$38K
Net Calls
+$80K
Net Calls Change
+$81K
Name Holding Trade Value Shares
Change
Shares
Change %
Nisa Investment Advisors
126
Nisa Investment Advisors
Missouri
$899 -$136 -16 -13%
HNB
127
Huntington National Bank
Ohio
$746
PCFFS
128
Pacific Center for Financial Services
California
$484
AAP
129
Arax Advisory Partners
Colorado
$484 +$484 +57 New
LC
130
Lindbrook Capital
California
$449 +$449 +53 New
FFA
131
Farther Finance Advisors
California
$196
JF
132
Jump Financial
Illinois
-$390K -43,447 Closed
Assenagon Asset Management
133
Assenagon Asset Management
Luxembourg
-$360K -40,166 Closed
AIG
134
American International Group
New York
-$215K -23,942 Closed
CC
135
Corton Capital
Ontario, Canada
-$134K -14,888 Closed
Principal Financial Group
136
Principal Financial Group
Iowa
-$132K -14,708 Closed
ProShare Advisors
137
ProShare Advisors
Maryland
-$110K -12,219 Closed
AI
138
Atom Investors
Texas
-$104K -11,576 Closed
CFM
139
Catalyst Funds Management
Australia
-$102K -11,410 Closed
Man Group
140
Man Group
United Kingdom
-$90.6K -10,101 Closed
CSS
141
Cubist Systematic Strategies
Connecticut
-$52.3K -5,834 Closed
MLICM
142
Metropolitan Life Insurance Company (MetLife)
New York
-$24.9K -2,773 Closed
NFSG
143
Newbridge Financial Services Group
Florida
-$8.97K -1,000 Closed
AWM
144
Avior Wealth Management
Nebraska
-$116 -13 Closed